Filter
269
Filtered Results: 269
Text search:
Ministry
of
Health
Saudi
Arabia
Featured
Recommendations
21
New Publications
56
Language
Document type
No document type
124
Studies & Reports
78
Guidelines
31
Strategic & Response Plan
12
Manuals
9
Situation Updates
6
Resource Platforms
4
Fact sheets
3
Training Material
1
Videos
1
Countries / Regions
Global
32
Yemen
14
Syria
11
Kenya
6
Middle East and North Africa
5
Ethiopia
5
India
5
Saudi Arabia
4
Bangladesh
4
South Sudan
4
Myanmar / Burma
4
China
3
Nigeria
3
Africa
3
Cambodia
3
South–East Asia Region
3
Uganda
3
Greece
3
Iraq
3
Somalia
3
Nepal
2
Thailand
2
Mexico
2
Sierra Leone
2
Burkina Faso
2
Afghanistan
2
Mozambique
2
Asia
2
Jordan
2
Lebanon
2
Palestine
2
Mali
2
Indonesia
2
Pakistan
2
Turkey
1
Ghana
1
Rwanda
1
Iran
1
Albania
1
Laos
1
Burundi
1
Malawi
1
Morocco
1
Philippines
1
Guinea
1
Armenia
1
Venezuela
1
Latin America and the Carribbean
1
Germany
1
Congo, Democratic Republic of
1
Western and Central Europe
1
Paraguay
1
Tunisia
1
East and Southern Africa
1
South Africa
1
Vietnam
1
Eastern Europe
1
Russia
1
Djibouti
1
Sudan
1
Georgia
1
Central African Republic
1
Libya
1
Botswana
1
Liberia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
63
Public Health
26
Clinical Guidelines
23
Key Resources
18
Women & Child Health
10
Capacity Building
6
Pharmacy & Technologies
2
Toolboxes
COVID-19
38
Mental Health
29
Conflict
17
Refugee
14
HIV
14
AMR
13
Rapid Response
12
Planetary Health
11
NTDs
10
Health Financing Toolbox
9
TB
8
Disability
7
Pharmacy
7
NCDs
6
Global Health Education
6
Caregiver
5
Ebola & Marburg
4
Polio
4
Cholera
2
Specific Hazards
1
Natural Hazards
1
Social Ethics
1
Malaria
1
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes.
Supporting exercises: These files are necessary for participants to complete a number of exercises listed in the man...
In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR national action plans that address the five objectives of the World Health Organization Global Action Plan (GAP) by...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
During the past five decades, the incidence of dengue has increased 30-fold. Some 50–100 million new infections are estimated to occur annually in more than 100 endemic countries, with a documented further spread to previously unaffected areas; every year hundreds of thousands of severe cases ari...
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-birth-weight data are described and recommendations a...
The WHO Vision and eye screening implementation handbook (VESIH) offers a step-by-step guidance for conducting vision and eye screenings in community and primary care settings. The evidence-based interventions are drawn from the WHO Package of eye care interventions and developed with a focus on del...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Patient safety assessment manual
recommended
3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO gu...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.
The report showed that while only 23 countries have implemented ce...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
